Evidence map›Paper›PMID 25052743›Full record

ArticleFuture oncology (London, England)2014

Engulfing losers by winners in cancer: do cancer stem cells catch eat-me signals from noncancer stem cells?

Ichiro Nakano

Abstract readEditorial
In one paragraph

Article in Future oncology (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ichiro Nakano

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The Tumor Microenvironmental Barrier to Effective Viral OncolysisP01CA163205 · NCI · OHIO STATE UNIVERSITY · PI MICHAEL A CALIGIURI · 2013 to 2026
$26.0M
Metabolism Informs Intertumoral & Intratumoral HeterogeneityR01NS087913 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NAKANO, ICHIRO, RICH, JEREMY N · 2014 to 2018
$2.0M
Targeting MELK-mediated EZH2 signaling in glioma stem cellsR01NS083767 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEE, JEONGWU, NAKANO, ICHIRO · 2013 to 2017
$1.3M
Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cellsR21CA175875 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAKANO, ICHIRO, PENALVA, LUIZ OTAVIO · 2014 to 2015
$377k
NCI NIH HHS P01 CA163205NCI NIH HHS P30 CA016058NCI NIH HHS R21 CA175875NINDS NIH HHS R01 NS083767NINDS NIH HHS R01 NS087913
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PhagocytosisAnimalsCell CommunicationHumansNeoplastic Stem CellsStem Cellsbrain tumorcompetitioncooperationGBMglioblastomaglioma stem cells

Identifiers

PMID25052743
PMCPMC4125125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.